Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co ElifiledCriticalLilly Co Eli
Publication of MX9709536ApublicationCriticalpatent/MX9709536A/en
Publication of MXPA97009536ApublicationCriticalpatent/MXPA97009536A/en
A method of inducing BEF-1 transcription factor comprising administering to a human in need thereof an effective amount of a compound having formula (I), wherein R1 and R3 are independently hydrogen, -CH3, (a), or (b), wherein Ar is optionally substituted phenyl; R2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.
MXPA/A/1997/009536A1995-06-071997-12-04Method to reduce the transcription factor be
MXPA97009536A
(en)